
NCRI 2019: Men over 40 with BRCA2 gene fault ‘should get regular PSA screening’
Guidelines should change so that all men over the age of 40 with faults in…
Guidelines should change so that all men over the age of 40 with faults in…
Men with the BRCA2 gene fault have an increased risk of prostate cancer and could…
Finasteride, a generic hormone-blocking drug, was found to reduce the risk of prostate cancer by…
A new study reveals declines in prostate cancer screening and diagnoses in the United States…
Shomik Sengupta, Monash University A recent UK study showed no significant difference in survival between…
An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a…
By Ian Haines, Monash University From the 1980s, when prostate screening became available, many men…
Starting in 1993 and ending in 2001, ten academic medical centers in the United States…
When it comes to prostate cancer biopsies, risk and reality don’t always match up, according…
Wendy Glamocak, ABC. About 100 patients in South Australia were given false positive results for…